MAMMOGRAPHY MARKET ANALYSIS

Market Size and Trends

The global mammography market is estimated to be valued at USD 2.60 Bn in 2024 and is expected to reach USD 5.14 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.2% from 2024 to 2031.

To learn more about this report, request a free sample copy

The global mammography market is experiencing strong growth owing to the increasing burden/incidence of cancer across the world, and increasing number of breast cancer screening programs/campaigns. Moreover, increasing number of mammography and biopsy procedures is expected to boost the growth of the market. However, factors such as risk of adverse effects from radiation exposure and growing emergence of other imaging or detection methods are expected to hamper the market growth.

Market Driver – Increasing Prevalence of Breast Cancer

Increasing burden/incidence of cancer across the world is expected to augment the growth of the global mammography market during the forecast period. For instance, mammograms are the best way to find breast cancer early, when it is easier to treat and before it is big enough to feel or cause symptoms. According to the World Cancer Research Fund International (WCRF), breast cancer is the most commonly occurring cancer in women and the most common cancer overall. There were more than 2.26 million new cases of breast cancer in women in 2020. According to World Health Organization, in 2019, cancer was the first or second leading cause of death in 112 of 183 countries.

Market Concentration and Competitive Landscape

To learn more about this report, request a free sample copy

Favorable initiatives for breast cancer screening or increase in the number of breast cancer screening programs or campaigns is expected to boost the market growth. For instance, in October 2020, the Kao Group of Japan, a manufacturer of household and chemical product, announced the launch of the ‘Kao Group Pink Ribbon Campaign 2020’ in major cities across Japan. The campaign has been running since 2007 to communicate the importance of the early detection of breast cancer to as many people as possible. Breast cancer is currently the most common type of cancer in Japanese females, driving the growth of the market.

To learn more about this report, request a free sample copy

Growing emergence of other imaging or detection methods, such as Magnetic Resonance Imaging (MRI), is expected to hinder the growth of the global mammography market. MRI of the breast, or breast MRI, is a test used to detect breast cancer and other abnormalities in the breast. MRI is much more sensitive compared to mammography and can find invasive breast cancers sooner than mammograms.

Market Opportunities – Increasing Number of Mammography and Biopsy Procedures

Increasing number of mammography and biopsy procedures is expected to offer significant growth opportunities for players in the global mammography market. For instance, according to the data provided by the U.S. Food & Drug Administration’s (USFDA) Mammography Quality Standards Act’s (MQSA) program, around 39,450,489 total annual mammography procedures were reported as of August 1, 2022 globally. Mammography is a specialized medical imaging tool that uses a low-dose x-ray system to see inside the breasts.

To learn more about this report, request a free sample copy

The product type segment includes digital systems, analog systems, film screen systems, and others. The digital systems sub-segment is estimated to hold 64.7% of the market share in 2024 owing to rapid technological advancements that have made digital mammography increasingly accessible and affordable. Digital systems offer clearer images than analog or film-based options and allow for enhanced detection capabilities. Digital mammograms can be electronically stored, transferred, and shared more easily than physical films. This has streamlined the diagnosis and review process for healthcare providers. The digital format also enables the use of supplementary imaging techniques like tomosynthesis that provide additional clinical benefits. Greater functionality along with lower costs compared to the past have boosted uptake of digital mammography systems among hospitals and clinics. Ongoing improvements to image quality, processing speeds, and other performance metrics continue to drive preference for digital over analog systems.

Insights, By Technology: Increased Clinical Utility Fuels the Adoption of Breast Tomosynthesis

The technology segment includes breast tomosynthesis, CAD mammography, and digital mammography. The breast tomosynthesis sub-segment is estimated to hold 54.1% of the market share in 2024 owing to its superior diagnostic abilities. Tomosynthesis takes multiple X-ray images of the breast from different angles to create 3D reconstruction of the tissue. This provides physicians with clearer views of abnormalities that may be obscured on a standard mammogram. Clinical studies have found tomosynthesis to be nearly 15% more effective at cancer detection than traditional two-dimensional mammography alone. Its improved accuracy has made tomosynthesis especially valuable for women with dense breast tissue. Growing evidence of the technique's benefits is convincing more healthcare facilities to invest in tomosynthesis equipment, pushing it to the forefront of mammography technology.

Insights, End User: Focus on Preventive Care Boosts the Hospital Mammography Usage

The end user segment includes hospitals, specialty clinics, diagnostic centers, and others. The hospitals sub-segment is estimated to hold 36.2% of the market share in 2024. As the primary points of medical access for communities, hospitals play a vital role in women's health screening and early cancer detection. They consistently offer mammography treatments and host dedicated breast screening programs to catch illnesses in earlier, more treatable stages. This proactive approach aligns with hospitals' emphasis on improving population health outcomes. Many also maintain in-house radiology departments with the latest mammogram technologies. The convenient access to mammography during other appointments draws high patient volumes to hospitals over alternate settings. Enhanced health education at hospitals has likewise raised consumer awareness about mammography's benefits, driving greater usage within this end user segment.

Regional Insights

To learn more about this report, request a free sample copy

North America remains the dominant region in the global mammography market and is estimated to hold 43.7% of the market share in 2024 owing to the increasing prevalence of breast cancer and increasing demand for early-stage diagnosis in the region. For instance, mammogram is the specialized medical imaging tool used to look for early signs of breast cancer. According to the Centers for Disease Control and Prevention (CDC), breast cancer is the second most common cancer among women in the U.S. Each year, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 in men in the U.S. About 42,000 women and 500 men in the U.S. die each year from breast cancer.

The Asia Pacific region has emerged as the fastest growing market due to the increasing burden of breast cancer, rise in breast cancer screening campaigns, and favorable government initiatives in the region. For instance, according to the study by GLOBOCAN 2020, in India, every four minutes a woman is diagnosed with breast cancer. With around 178,000 new cases being diagnosed every year, the incidence of breast cancer has overtaken cervical cancer to become the most common cancer in Indian women. Thus, with the increase in burden of breast cancer, the use of mammogram is also increasing rapidly.

Market Report Scope

Key Developments

• On April 17, 2024, Siemens Healthineers, a medical device company, announced that it had launched Mammomat B.brilliant1, a new tomosynthesis mammography system with a wide-angle tube that moves around the breast at a 50° angle and a scan time of around five seconds, creating a 3D image with high depth resolution in the shortest time possible. The system enables abnormalities and microcalcifications in the tissue to be identified with a high level of accuracy.
• In November 2023, University of Rochester Medical Center Rochester, U.S. launched Mobile Mammography Van, equipped with state-of-the-art, 3D breast imaging technology. It provides important preventive care for women throughout the Rochester, Finger Lakes, and Western New York region in the U.S.
• In November 2023, GE Healthcare, a healthcare company, announced the launch of MyBreastAI Suit, an all-in-one platform of artificial intelligence (AI) app to support clinicians with breast cancer detection and improved workflow productivity. MyBreastAI Suite integrates three artificial intelligence (AI) applications from iCAD including ProFound AI for DBT, SecondLook for 2D Mammography and PowerLook Density Assessment to help support early detection and improve patient outcomes, as well as help radiology departments improve operational productivity.
• In March 2021, the World Health Organization (WHO), in collaboration with the International Agency for Research on Cancer (IARC) and the International Atomic Energy Agency (IAEA), launched the Global Breast Cancer Initiative. The Global Breast Cancer Initiative will focus efforts on the potential of multisectoral partnerships, programmes that promote sustainable capacity-building, and innovation and monitoring systems that use data for decision-making.
• In December 2020, Hologic Inc., a medical technology company primarily focused on improving women’s health, announced the U.S. Food and Drug Administration (FDA) clearance and commercial availability of the Genius AI Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.
• In October 2020, Siemens Healthineers, a medical device company, received clearance from the U.S. Food and Drug Administration (FDA) for Ysio Max digital radiography system which includes new detectors and usability features that improve imaging and speed up exams

*Definition: A mammography exam, a mammogram, aids in the early detection and diagnosis of breast diseases in women. Mammography is a specialized medical imaging tool that uses a low-dose x-ray system to see inside the breasts. Regular mammograms are the best tests doctors have to find breast cancer early. 

Market Segmentation

•  Product Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Digital Systems
  • Analog Systems
  • Film Screen Systems
  • Others
•  Technology Insights (Revenue, USD Bn, 2019 - 2031)
  • Breast Tomosynthesis
  • CAD Mammography
  • Digital Mammography
•  End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Others
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Carestream Health
  • Siemens Healthineers
  • Planmed Oy
  • Konica Minolta Inc.
  • Metaltronica SpA
  • Koninklijke Philips N.V.
  • General Medical Merate SpA
  • Hologic Inc.
  • GE Healthcare
  • Fujifilm Holdings Corporation
  • Analogic Corporation
  • Canon Medical Systems Corporation
  • Toshiba Medical Systems